Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sherwin

Showing results (101-110 of 170) with videos related to

Pageof 17
Sort By:
The New Zealand Medical Journal|October 28, 2008
Netilmicin withdrawal: impact on neonatesCatherine M T Sherwin, Sofia Svahn, Roland S Broadbent, et al.
Frontiers in Pharmacology|February 13, 2023
Current use of complementary and conventional medicine for treatment of pediatric patients with gastrointestinal disordersCasey L Sayre, Venkata Kashyap Yellepeddi, Kathleen M Job, et al.
Pediatric Pulmonology|September 6, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodiumDavid C Young, Jeffery T Zobell, C Dustin Waters, et al.
Clinical Pharmacokinetics|May 30, 2014
Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infantsJessica K Roberts, Chris Stockmann, Jonathan E Constance, et al.
Clinical Pharmacokinetics|May 21, 2015
Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic EncephalopathyJessica K Roberts, Chris Stockmann, Robert M Ward, et al.
The AAPS Journal|May 30, 2019
Population Pharmacokinetic Modeling in the Presence of Missing Time-Dependent Covariates: Impact of Body Weight on Pharmacokinetics of Paracetamol in NeonatesWojciech Krzyzanski, Sarah F Cook, Melanie Wilbaux, et al.
Pediatric Pulmonology|September 6, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillinsJeffery T Zobell, C Dustin Waters, David C Young, et al.
Pediatric Pulmonology|August 23, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenemsJeffery T Zobell, David C Young, C Dustin Waters, et al.
Pediatric Pulmonology|January 30, 2013
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summaryJeffery T Zobell, David C Young, C Dustin Waters, et al.
Pediatric Pulmonology|September 4, 2013
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. AminoglycosidesDavid C Young, Jeffery T Zobell, Chris Stockmann, et al.
Pageof 17

Showing results (101-110 of 170) with videos related to

Sort By:
Pageof 17
The New Zealand Medical Journal|October 28, 2008
Netilmicin withdrawal: impact on neonatesCatherine M T Sherwin, Sofia Svahn, Roland S Broadbent, et al.
Frontiers in Pharmacology|February 13, 2023
Current use of complementary and conventional medicine for treatment of pediatric patients with gastrointestinal disordersCasey L Sayre, Venkata Kashyap Yellepeddi, Kathleen M Job, et al.
Pediatric Pulmonology|September 6, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodiumDavid C Young, Jeffery T Zobell, C Dustin Waters, et al.
Clinical Pharmacokinetics|May 30, 2014
Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infantsJessica K Roberts, Chris Stockmann, Jonathan E Constance, et al.
Clinical Pharmacokinetics|May 21, 2015
Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic EncephalopathyJessica K Roberts, Chris Stockmann, Robert M Ward, et al.
The AAPS Journal|May 30, 2019
Population Pharmacokinetic Modeling in the Presence of Missing Time-Dependent Covariates: Impact of Body Weight on Pharmacokinetics of Paracetamol in NeonatesWojciech Krzyzanski, Sarah F Cook, Melanie Wilbaux, et al.
Pediatric Pulmonology|September 6, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillinsJeffery T Zobell, C Dustin Waters, David C Young, et al.
Pediatric Pulmonology|August 23, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenemsJeffery T Zobell, David C Young, C Dustin Waters, et al.
Pediatric Pulmonology|January 30, 2013
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summaryJeffery T Zobell, David C Young, C Dustin Waters, et al.
Pediatric Pulmonology|September 4, 2013
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. AminoglycosidesDavid C Young, Jeffery T Zobell, Chris Stockmann, et al.
Pageof 17